Healthy outlook on life!
MEDIPAL is a modern, high-performance distribution company. It is amongst Top 10 pharmaceutical leading suppliers under government contracts in the Russian Federation.Learn more
TOP 10ranking among
>25 yearsof successful operation
15 officesand representative offices
> 250partners in the pharmaceutical industry
Draw on experience and knowledge to be the best at everything and stay on target. To unite and inspire a team of like-minded people constantly moving forward. To develop our success by acting responsibly, innovating, and improving the quality of life and the health of people.
Everything we do is based on the corporate values that we defined for ourselves as a priority at the very beginning of our activity: responsibility, development, humanity, success.
For more than 25 years MEDIPAL has been a successful company demonstrating steady growth, social responsibility and confident development prospects.
Charitable activities are an integral part of the company’s overall strategy. For many years we have been active participants in various social programs and initiatives.
Corporate reputation is one of the keys to business success. We are convinced that in addition to complying with all laws and regulations, it is important to act in accordance with the highest ethical and moral standards.
On June 15-16 of this year, the First International Pharmaceutical Forum was held in Tashkent, organized by the Ministry of Investments and Foreign Trade of the Republic of Uzbekistan, the Agency for the Development of the Pharmaceutical Industry, as well as the Association of Representative Offices of Foreign Pharmaceutical Companies and Manufacturers in the Republic of Uzbekistan.
Congratulations on the Day of the Medical worker!
The First International Pharmaceutical Forum was held in Tashkent on June 15-16.
May the creative spirit of this holiday give everyone creative inspiration and bring professional success.
Sergey Sobyanin held a meeting with representatives of major pharmaceutical companies where they discussed the development of the industry and import substitution in conditions of external sanctions pressure.
The government has approved the rules for the import into and export from the Russian Federation of biomaterials obtained during clinical trials of medicines for human use. They will come into force on September 1 and will be valid until September 1, 2028; a corresponding decree of the Russian government has been published on the official Internet portal of legal information.
The Ministry of Industry and Trade called pharmaceuticals a priority area for import substitution, which will meet all the country's needs for medicinal products for treatment of socially significant diseases. According to the Minister, the next stage of import substitution is aimed at the formation of independence for biological and chemical substances, raw materials and equipment.
“To improve the quality and accessibility of medical care for patients with rare diseases, it is necessary to form a national orphan program, Sergey Kutsev, Director of Medical Genetics Scientific Center named after the Academician N.P. Bochkov, believes.
Every year on February 4, World Cancer Day is celebrated. On this occasion, the Russian Society of Oncohematologists and the Russian Association of Oncologists held a discussion on the topic "Oncohematology: to act instead of putting off."
Our success is determined by our team — a team of caring people who share common values
Many years ago we chose health care as our mission and over the years of our development we have become a large professional company, earned a reputation of a reliable partner and gained a leading position in the industry. Today we are looking into the future with confidence.
Our partners include more than 250 leading Russian and foreign manufacturers of medicines and medical products.